Evidence map›Paper›PMID 33228663›Full record

ArticleJournal of translational medicine2020

LncRNA NEAT1/microRNA-129-5p/SOCS2 axis regulates liver fibrosis in alcoholic steatohepatitis.

Junfeng Ye, Yuanqiang Lin, Ying Yu, Di Sun

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 91 citations in OpenAlex.

  1. Trial
  2. Unifying and unique roles of non-coding RNA biomarkers in liver and heart fibrosis.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026
    Review
  3. Article
  4. Non-coding RNAs in alcohol-associated liver disease.Liver research (Beijing, China) · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Prospective therapeutics for intestinal and hepatic fibrosis.Bioengineering & translational medicine · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Junfeng YeDepartment of Hepato-Biliary-Pancreatic Surgery, First Hospital, Jilin University, Changchun, 130021, Jilin, People's Republic of China.
Yuanqiang LinDepartment of Ultrasonography, China-Japan Union Hospital, Jilin University, Changchun , 130021, Jilin, People's Republic of China.
Ying YuDepartment of Hepato-Biliary-Pancreatic Surgery, First Hospital, Jilin University, Changchun, 130021, Jilin, People's Republic of China.
Di SunDepartment of Colorectal & Anal Surgery, First Hospital, Jilin University, No. 71 Xinmin street, Changchun, 130021, Jilin, People's Republic of China. Sundi2332@163.com.
Jilin University · CN

Funding

Wu Jieping Medical Foundation (The role of KLF2 in the development of hepatocellular carcinoma and in the Regulation of Hedgehog signal pathway) 320.6750.17217
6 · The paper itself

Abstract

backgroundLong non-coding RNA nuclear paraspeckle assembly transcript 1 (NEAT1) has been reported to play an essential role in non-alcoholic fatty liver disease. However, the role of NEAT1 in regulation of alcoholic steatohepatitis (ASH) remains largely unknown. This study aims to explore the role of NEAT1 in ASH by mediating microRNA-129-5p (miR-129-5p) targeting suppressor of cytokine signaling 2 (SOCS2).

methodsNEAT1, miR-129-5p and SOCS2 expression in serum of ASH patients were assessed. In the in vitro cellular experiment, we transfected siRNAs, oligonucleotides or plasmids into ethanol-induced AML-12 mouse hepatocytes to alter NEAT1 and miR-129-5p expression, and inflammatory factors and lipid content were determined. In the in vivo animal experiment, we injected lentiviruses carrying siRNAs, oligonucleotides or plasmids onto ASH mice (ASH induced by feeding mice a Lieber-DeCarli ethanol diet) to alter NEAT1 and miR-129-5p expression through the tail vein. Serum liver function, blood lipids and inflammatory factors were detected; liver histopathology, liver cell apoptosis, and fibrosis were observed. The relationship between NEAT1 and miR-129-5p, or between miR-129-5p and SOCS2 was verified.

resultsMiR-129-5p was reduced while NEAT1 and SOCS2 were elevated in ASH. Inhibited NEAT1 or elevated miR-129-5p suppressed the elevated lipid metabolism and restrained inflammation reaction in ethanol-stimulated AML-12 cells. The promoted miR-129-5p and inhibited NEAT1 could improve the liver function and repress blood lipid, inflammation reaction, hepatocyte apoptosis and liver fibrosis in ethanol-induced ASH mice. Furthermore, NEAT1 could negatively regulate miR-129-5p to target SOCS2.

conclusionWe have found that the inhibited NEAT1 could suppress liver fibrosis in ASH mice by promoting miR-129-5p and restraining SOCS2, thereby decelerating the development of ASH.

Indexed as

Fatty Liver, AlcoholicLiver CirrhosisMicroRNAsRNA, Long NoncodingSuppressor of Cytokine Signaling ProteinsAnimalsCell ProliferationGene Expression Regulation, NeoplasticHumansMiceMicroRNAsMirn129 microRNA, humanNEAT1 long non-coding RNA, humanRNA, Long NoncodingSOCS2 protein, humanSuppressor of Cytokine Signaling ProteinsAlcoholic steatohepatitisLiver fibrosisLong non-coding RNA nuclear paraspeckle assembly transcript 1MicroRNA-129-5pSuppressor of cytokine signaling 2

Identifiers

PMID33228663
PMCPMC7686721
OpenAlexW3108874111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.